Detalhe da pesquisa
1.
Incidence of Guillain-Barré syndrome following SARS-CoV-2 immunization: Analysis of a nationwide registry of recipients of 81 million doses of seven vaccines.
Eur J Neurol;
29(11): 3368-3379, 2022 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35841212
2.
Guillain-Barré syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine.
Clin Immunol;
230: 108818, 2021 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34358692
3.
Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study.
Clin Immunol;
229: 108786, 2021 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34147649
4.
Epidemiological and clinical characteristics of patients with human monkeypox infection in Mexico: a nationwide observational study.
Lancet Reg Health Am;
17: 100392, 2023 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36405887
5.
Effectiveness of a nationwide COVID-19 vaccination program in Mexico against symptomatic COVID-19, hospitalizations, and death: a retrospective analysis of national surveillance data.
Int J Infect Dis;
129: 188-196, 2023 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36775188
6.
Psychological and Psychiatric Events Following Immunization with Five Different Vaccines against SARS-CoV-2.
Vaccines (Basel);
10(8)2022 Aug 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36016185
7.
Stroke Among SARS-CoV-2 Vaccine Recipients in Mexico: A Nationwide Descriptive Study.
Neurology;
98(19): e1933-e1941, 2022 05 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35277439
8.
Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: A case-control study.
Vaccine;
39(48): 6975-6979, 2021 11 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34742595